Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?

Sobia Mujtaba, Jorge Romero, Cynthia C. Taub

Research output: Contribution to journalReview articlepeer-review

43 Scopus citations

Abstract

Methadone is a drug that has found widespread utility in the management of opioid addiction and pain. Along with its popularity, methadone has also earned an infamous reputation for causing prolongation of the QT interval and an increased risk of torsades de pointes. In this article we will give a brief overview of the long QT syndromes, followed by an in-depth look at the current pathophysiologic mechanisms of methadone induced QT prolongation, a review of the existing literature and the current concepts regarding the prevention and management of methadone induced torsades de pointes. In addition, we explore the idea and implications of a genetic link between methadone induced prolongation of the QT interval and torsades de pointes

Original languageEnglish (US)
Pages (from-to)229-235
Number of pages7
JournalJournal of Cardiovascular Disease Research
Volume4
Issue number4
DOIs
StatePublished - Dec 2013

Keywords

  • Methadone
  • Pharmacogenetics
  • QT-prolongation
  • Torsades de pointes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?'. Together they form a unique fingerprint.

Cite this